PA Medical News about Menstrual Cycle Migraine Disorders Contraceptives, Oral, Hormonal

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hormonal Therapies for Menstrual Migraine
Current Pain and Headache Reports, 09/17/09

Calhoun AH et al. – Menstrual–related migraine (MRM) affects the majority of female migraineurs, with menstrual–associated attacks reported to be more disabling, longer lasting, and less responsive to traditional treatments than nonmenstrual attacks. Emerging evidence suggests that minimizing or eliminating monthly declines in estrogen concentration may be effective in preventing MRM. This article gives a practical overview of current hormonal options, both contraceptive and noncontraceptive. Our intent is to help the reader better understand the differences in currently available formulations and how some of these agents may be utilized as hormonal preventives of MRM.

Oral Contraceptives May Benefit Women With Asthma
ScienceDaily, 11/06/09 Relevance Score: 88%

Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance
Human Reproduction, 10/20/09 Relevance Score: 88%

Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
Headache: The Journal of Head and Face Pain, 10/15/09 Relevance Score: 88%

Increased Dopamine Is Associated With the cGMP and Homocysteine Pathway in Female Migraineurs
Headache: The Journal of Head and Face Pain, 10/07/09 Relevance Score: 86%

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09 Relevance Score: 81%